-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Introduction Chronic lymphocytic leukemia (CLL) is the most common B-cell chronic lymphoproliferative disease, which is characterized by the accumulation of mature small lymphocytes in peripheral blood, bone marrow, spleen and lymph nodes
.
In recent years, with the increasing trend of population aging in our country, and the awareness of public health disease screening has increased, the incidence of CLL has shown an obvious upward trend
.
Global tumor treatment has entered the era of precision medicine, and standardized diagnosis and treatment are becoming increasingly important
.
In 2017, the Chinese Workshop on CLL (cwCLL) was established to build an internationally leading CLL center, promote the standardized construction of CLL diagnosis and treatment, and improve the overall academic level of CLL
.
After five years, it has grown from the original 7 core members and 82 committee members to 21 local working groups, covering more than 300 hospitals, and growing
.
In 2020, the Chinese College of CLL (CCC) was established to launch an online CLL standardized diagnosis and treatment course, bringing together the standardized diagnosis and treatment experience of major blood tumor centers in China for the exchange and learning of hematologists across the country
.
The “China Chronic Lymphology Working Group Conference on the Standardization of Diagnosis and Treatment Pathways-CLL Standards for the Future” is a CLL standardized academic journey based on cwCLL
.
The event started in January 2021 and lasted for 10 months.
A total of 8 fierce standardized case competitions were held.
In the end, 8 young talents who stood out from all over the world successfully entered the finals and jointly performed a wonderful CLL year.
Race
.
Wonderful event On December 12, 2021, the China Chronic Lymphology Institute-CLL standardized case finals officially kicked off
.
The conference was chaired by Professor Li Jianyong from Jiangsu Provincial People’s Hospital, Professor Ma Jun from Harbin Institute of Hematology and Tumor, and Professor Wang Xin from Shandong Provincial Hospital.
Professor Zhou Jianfeng from Tongji Hospital of Tongji Medical College of Huazhong University of Science and Technology and Xu Professor Wei, Professor Jin Jie from the First Affiliated Hospital of Zhejiang University School of Medicine, Professor Mi Jianqing from Ruijin Hospital Affiliated to Shanghai Jiaotong University School of Medicine, Professor Zhang Xi from Xinqiao Hospital of Army Military Medical University, and Professor Feng Ru from Nanfang Hospital of Southern Medical University chaired the meeting.
Professor Wang Shaoyuan from Union Hospital of Medical University, Professor Peng Hongling from the Second Xiangya Hospital of Central South University, Professor Zhou Keshu from Henan Tumor Hospital, Professor Yi Shuhua from Hospital of Hematology, Chinese Academy of Medical Sciences, Professor Su Liping from Cancer Hospital of Shanxi Medical University, Bethune First Hospital of Jilin University Professor Bai Ou, Professor Yang Wei of Shengjing Hospital Affiliated to China Medical University, and Professor Zeng Yun of the First Affiliated Hospital of Kunming Medical University served as panelists
.
The contestants in this final are: Dr.
Zhou Dian from Xuzhou Medical University Affiliated Hospital, Dr.
Geng Haili from Union Hospital Affiliated to Fujian Medical University, Dr.
Xiang Qianqian from Xinqiao Hospital of Army Military Medical University, Dr.
Zhang Jiaojiao from Ruijin Hospital Affiliated to Shanghai Jiaotong University School of Medicine, Dr.
Shen Jing, Shengjing Hospital Affiliated to China Medical University, Dr.
Guo Xutao, Nanfang Hospital of Southern Medical University, Dr.
Tan Ningning, Shandong Provincial Hospital, and Zheng Meijing, Shanxi Cancer Hospital
.
At the beginning of the conference, the chairmen, Professor Ma Jun, Professor Li Jianyong, and Professor Wang Xin gave opening remarks.
First, they affirmed the positive significance of the online and offline diagnosis and treatment standards meeting held by cwCLL in the past five years, and unanimously emphasized that the standardization of CLL diagnosis and treatment must be emphasized.
Only in order to enable patients to achieve a higher clinical cure, can doctors follow and have medicine to cure
.
It is hoped that in this competition, judges, discussion experts and contestants will jointly analyze and discuss real cases and improve the standardization of CLL diagnosis and treatment
.
After the chairman's speech, the 8 contestants demonstrated their cases, each of them narrated the diagnosis and treatment experience of different CLL patients, and the leaders of local working groups from all over the country provided wonderful comments and questions on the cases, and the live discussions were enthusiastic and rewarding.
Quite a lot
.
The eight doctors fully demonstrated their professional knowledge and personal >
.
At the end of the meeting, Professor Li Jianyong fully affirmed the clinical experience and on-the-spot performance of the 8 contestants, and expressed his gratitude to the experts for their professional comments
.
He concluded: The clinical cases brought by the 8 contestants are very representative.
This competition not only examined the CLL diagnosis and treatment capabilities of doctors, but also analyzed the clinical application of Ibrutinib in detail
.
Whether it is from the production of speeches, slides, or from the logic of answering questions, the players’ knowledge reserves and clinical abilities are examined
.
Professor Li Jianyong indicated that in clinical practice, more attention should be paid to the standardized diagnosis and treatment, evaluation, prognosis and follow-up of CLL, and at the same time to promote the overall management strategy of patients.
The ultimate goal is to allow patients to get better treatment, promote patient recovery, and improve the quality of life of patients
.
Finally, Professor Li Jianyong announced the results of the final: First prize: Dr.
Guo Xutao, Nanfang Hospital, Southern Medical University Second prize: Dr.
Haili Geng, Dr.
Geng Haili, Union Hospital Affiliated to Fujian Medical University, Dr.
Zhang Jiaojiao, Ruijin Hospital Affiliated to Shanghai Jiaotong University School of Medicine, Third prize: Dr.
Zhou Dian, Affiliated Hospital of Xuzhou Medical University, Dr.
Xiang Qianqian, Xinqiao Hospital, Army Military Medical University, Dr.
Shen Jing, Shengjing Hospital, Affiliated to China Medical University, Dr.
Tanning Ning, Shandong Provincial Hospital, Dr.
Zheng Meijing, Shanxi Cancer Hospital, 2021 "China Chronic Lymphocyte Working Group Diagnosis and Treatment The “Path Standardization Conference-CLL Standardizes the Future” event came to a successful conclusion, but the road to standardized diagnosis and treatment of CLL still has a long way to go.
It needs to be strengthened in daily work to benefit more CLL patients! At the end of the conference, the experts took a group photo on the cloud, and the conference ended successfully! Poke "read the original text", we make progress together
.
In recent years, with the increasing trend of population aging in our country, and the awareness of public health disease screening has increased, the incidence of CLL has shown an obvious upward trend
.
Global tumor treatment has entered the era of precision medicine, and standardized diagnosis and treatment are becoming increasingly important
.
In 2017, the Chinese Workshop on CLL (cwCLL) was established to build an internationally leading CLL center, promote the standardized construction of CLL diagnosis and treatment, and improve the overall academic level of CLL
.
After five years, it has grown from the original 7 core members and 82 committee members to 21 local working groups, covering more than 300 hospitals, and growing
.
In 2020, the Chinese College of CLL (CCC) was established to launch an online CLL standardized diagnosis and treatment course, bringing together the standardized diagnosis and treatment experience of major blood tumor centers in China for the exchange and learning of hematologists across the country
.
The “China Chronic Lymphology Working Group Conference on the Standardization of Diagnosis and Treatment Pathways-CLL Standards for the Future” is a CLL standardized academic journey based on cwCLL
.
The event started in January 2021 and lasted for 10 months.
A total of 8 fierce standardized case competitions were held.
In the end, 8 young talents who stood out from all over the world successfully entered the finals and jointly performed a wonderful CLL year.
Race
.
Wonderful event On December 12, 2021, the China Chronic Lymphology Institute-CLL standardized case finals officially kicked off
.
The conference was chaired by Professor Li Jianyong from Jiangsu Provincial People’s Hospital, Professor Ma Jun from Harbin Institute of Hematology and Tumor, and Professor Wang Xin from Shandong Provincial Hospital.
Professor Zhou Jianfeng from Tongji Hospital of Tongji Medical College of Huazhong University of Science and Technology and Xu Professor Wei, Professor Jin Jie from the First Affiliated Hospital of Zhejiang University School of Medicine, Professor Mi Jianqing from Ruijin Hospital Affiliated to Shanghai Jiaotong University School of Medicine, Professor Zhang Xi from Xinqiao Hospital of Army Military Medical University, and Professor Feng Ru from Nanfang Hospital of Southern Medical University chaired the meeting.
Professor Wang Shaoyuan from Union Hospital of Medical University, Professor Peng Hongling from the Second Xiangya Hospital of Central South University, Professor Zhou Keshu from Henan Tumor Hospital, Professor Yi Shuhua from Hospital of Hematology, Chinese Academy of Medical Sciences, Professor Su Liping from Cancer Hospital of Shanxi Medical University, Bethune First Hospital of Jilin University Professor Bai Ou, Professor Yang Wei of Shengjing Hospital Affiliated to China Medical University, and Professor Zeng Yun of the First Affiliated Hospital of Kunming Medical University served as panelists
.
The contestants in this final are: Dr.
Zhou Dian from Xuzhou Medical University Affiliated Hospital, Dr.
Geng Haili from Union Hospital Affiliated to Fujian Medical University, Dr.
Xiang Qianqian from Xinqiao Hospital of Army Military Medical University, Dr.
Zhang Jiaojiao from Ruijin Hospital Affiliated to Shanghai Jiaotong University School of Medicine, Dr.
Shen Jing, Shengjing Hospital Affiliated to China Medical University, Dr.
Guo Xutao, Nanfang Hospital of Southern Medical University, Dr.
Tan Ningning, Shandong Provincial Hospital, and Zheng Meijing, Shanxi Cancer Hospital
.
At the beginning of the conference, the chairmen, Professor Ma Jun, Professor Li Jianyong, and Professor Wang Xin gave opening remarks.
First, they affirmed the positive significance of the online and offline diagnosis and treatment standards meeting held by cwCLL in the past five years, and unanimously emphasized that the standardization of CLL diagnosis and treatment must be emphasized.
Only in order to enable patients to achieve a higher clinical cure, can doctors follow and have medicine to cure
.
It is hoped that in this competition, judges, discussion experts and contestants will jointly analyze and discuss real cases and improve the standardization of CLL diagnosis and treatment
.
After the chairman's speech, the 8 contestants demonstrated their cases, each of them narrated the diagnosis and treatment experience of different CLL patients, and the leaders of local working groups from all over the country provided wonderful comments and questions on the cases, and the live discussions were enthusiastic and rewarding.
Quite a lot
.
The eight doctors fully demonstrated their professional knowledge and personal >
.
At the end of the meeting, Professor Li Jianyong fully affirmed the clinical experience and on-the-spot performance of the 8 contestants, and expressed his gratitude to the experts for their professional comments
.
He concluded: The clinical cases brought by the 8 contestants are very representative.
This competition not only examined the CLL diagnosis and treatment capabilities of doctors, but also analyzed the clinical application of Ibrutinib in detail
.
Whether it is from the production of speeches, slides, or from the logic of answering questions, the players’ knowledge reserves and clinical abilities are examined
.
Professor Li Jianyong indicated that in clinical practice, more attention should be paid to the standardized diagnosis and treatment, evaluation, prognosis and follow-up of CLL, and at the same time to promote the overall management strategy of patients.
The ultimate goal is to allow patients to get better treatment, promote patient recovery, and improve the quality of life of patients
.
Finally, Professor Li Jianyong announced the results of the final: First prize: Dr.
Guo Xutao, Nanfang Hospital, Southern Medical University Second prize: Dr.
Haili Geng, Dr.
Geng Haili, Union Hospital Affiliated to Fujian Medical University, Dr.
Zhang Jiaojiao, Ruijin Hospital Affiliated to Shanghai Jiaotong University School of Medicine, Third prize: Dr.
Zhou Dian, Affiliated Hospital of Xuzhou Medical University, Dr.
Xiang Qianqian, Xinqiao Hospital, Army Military Medical University, Dr.
Shen Jing, Shengjing Hospital, Affiliated to China Medical University, Dr.
Tanning Ning, Shandong Provincial Hospital, Dr.
Zheng Meijing, Shanxi Cancer Hospital, 2021 "China Chronic Lymphocyte Working Group Diagnosis and Treatment The “Path Standardization Conference-CLL Standardizes the Future” event came to a successful conclusion, but the road to standardized diagnosis and treatment of CLL still has a long way to go.
It needs to be strengthened in daily work to benefit more CLL patients! At the end of the conference, the experts took a group photo on the cloud, and the conference ended successfully! Poke "read the original text", we make progress together
